50/50 Split: BioNTech and the Pfizer Illusion
Why is there so much focus on Pfizer in public discussion of the Covid vaccine market, virtually to the exclusion of BioNTech and even in discussion by seasoned financial analysts?
50/50 Split: BioNTech and the Pfizer Illusion
Why is there so much focus on Pfizer in public discussion of the Covid vaccine market, virtually to the exclusion of BioNTech and even in discussion by seasoned financial analysts?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
